Asset Management One
ACHN

Asset Management One’s Achillion Pharmaceuticals ACHN Stock Holding History

Asset Management One’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-527,557
Closed -$4.18M – 1308
2016
Q3 		$4.18M Sell
527,557
-51,852
-9% -$441K 0.06% 363
2016
Q2 		$4.54M Sell
579,409
-119,176
-17% -$1.02M 0.07% 333
2016
Q1 		$5.25M Sell
698,585
-170
-0% -$1.25K 0.08% 291
2015
Q4 		$7.28M Buy
698,755
+16,122
+2% +$147K 0.11% 221
2015
Q3 		$4.48M Buy
682,633
+16,179
+2% +$132K 0.07% 354
2015
Q2 		$5.7M Buy
666,454
+67,836
+11% +$642K 0.08% 336
2015
Q1 		$6.13M Buy
598,618
+171,780
+40% +$2.14M 0.08% 331
2014
Q4 		$5.4M Sell
426,838
-153,801
-26% -$1.88M 0.07% 361
2014
Q3 		$6.25M Buy
+580,639
New +$5.39M 0.09% 280

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Asset Management One's ACHN Position: Q4 2016 in Review

Asset Management One sold out of Achillion Pharmaceuticals (ACHN) in Q4 2016, closing a stake of 527,557 shares — an estimated $4.18M sold.

Asset Management One first reported a position in ACHN in Q3 2014 and held it in 9 quarters. The position peaked at $7.28M in Q4 2015. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

  • Asset Management One reported no remaining Achillion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 527,557 Achillion Pharmaceuticals shares in Q4 2016, an estimated $4.18M.
  • Asset Management One first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 9 quarters.
  • Asset Management One's Achillion Pharmaceuticals position peaked at $7.28M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.